National Survey on Drug Use and Health

The Ad Council, CDC, National Council for Mental Wellbeing and Shatterproof Launch Joint Effort to Inspire Millions Living with or At Risk for Substance Use Disorders to Begin their Recovery Journeys

Retrieved on: 
Wednesday, November 1, 2023
National Council, Government, HHS, Policy, Ageing, Love, PSA, NYSE, Unitary state, Korea Disease Control and Prevention Agency, Hope, National Survey on Drug Use and Health, Naloxone, SUD, Mental health, Multimedia, Mental, Smokey Bear, Advertising, Quality of life, Drug overdose, CDC, Council, Factitious disorder, Risk, Marketing, Ad Council, PSAS, SAMHSA, Partnership, Safety, Office of Inspector General, U.S. Department of Health and Human Services, Social change, Anxiety, Depression, KFF, Suds, Hearing, State, Dietary supplement, Nursing, Tourism, Pharmaceutical industry, Vaccine, Black, Health, The 39 Clues, Accenture

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- The Ad Council, in partnership with the Centers for Disease Control and Prevention (CDC), National Council for Mental Wellbeing and Shatterproof, is inspiring millions to "Start With Hope" in a national public service advertisement (PSA) campaign. This vital new effort aims to deliver a message of hope to those living with substance use disorders (SUDs) as well as those at risk of developing a SUD, with a focus on supporting Black and Hispanic/Latinx populations, connecting them with harm reduction strategies and treatment resources to start their journeys to wellbeing and recovery.

Key Points: 
  • Due to compounding inequities including stigma, accessibility barriers and racial bias, these communities often have lower access to substance use treatment services.
  • It is critical that individuals can access culturally-responsive harm reduction and treatment options to support their paths toward wellbeing and recovery.
  • Hope can also serve as a strong predictor of outcomes focused on well-being and quality of life.
  • If you are experiencing anxiety, depression, or a substance use disorder, text SHATTERPROOF to 741741 for help.

Harris Teeter to host drug take-back event on Oct. 28 at four store locations

Retrieved on: 
Friday, October 27, 2023
Substance Abuse and Mental Health Services Administration, Third Eye Shoppe, SAFE, Family, Plasma protein binding, DEA, Psychological abuse, Friends, National Survey on Drug Use and Health, Partnership, Mental health service, Substance Abuse, Davis Lake, Pharmaceutical industry, Health

MATTHEWS, N.C., Oct. 27, 2023 /PRNewswire-PRWeb/ -- Harris Teeter will host a drug take-back event at four of its Charlotte locations from 10 a.m. – 2 p.m. on Saturday, Oct. 28, 2023 , as part of the U.S. Drug Enforcement Administration's National Prescription Drug Take-Back Day. These events will provide a safe, convenient and anonymous way for local residents to dispose of unused or expired medications.

Key Points: 
  • MATTHEWS, N.C., Oct. 27, 2023 /PRNewswire-PRWeb/ -- Harris Teeter will host a drug take-back event at four of its Charlotte locations from 10 a.m. – 2 p.m. on Saturday, Oct. 28, 2023 , as part of the U.S. Drug Enforcement Administration's National Prescription Drug Take-Back Day.
  • These events will provide a safe, convenient and anonymous way for local residents to dispose of unused or expired medications.
  • The goal is to help the police department keep medications off the street by proper disposal of prescription medications, and knowing the dangers associated with drug abuse.
  • You can find more information about Harris Teeter's commitment to drug disposal solutions on our website.

SAMHSA Selects JPA Health to Spearhead National Recovery Campaign

Retrieved on: 
Thursday, October 26, 2023
Substance Abuse and Mental Health Services Administration, Substance Abuse, National Survey on Drug Use and Health, NSDUH, Create, SAMHSA, Mental health, Nursing, Health

WASHINGTON, Oct. 26, 2023 /PRNewswire/ -- JPA Health today announced that it has been awarded a multi-year, multi-million-dollar contract from the Substance Abuse and Mental Health Services Administration (SAMHSA) to support a national effort to jointly address recovery from mental health and/or substance use disorders among young adults.

Key Points: 
  • WASHINGTON, Oct. 26, 2023 /PRNewswire/ -- JPA Health today announced that it has been awarded a multi-year, multi-million-dollar contract from the Substance Abuse and Mental Health Services Administration (SAMHSA) to support a national effort to jointly address recovery from mental health and/or substance use disorders among young adults.
  • In light of these trends, JPA Health and its partner ICF Next have been tasked with helping SAMHSA develop and launch a National Recovery Campaign encouraging young adults to seek or continue treatment for substance use disorder and/or mental illness.
  • "We are honored to help SAMHSA implement a national recovery campaign for young adults who are disproportionately affected by mental illness and substance misuse," said Carrie Jones, CEO of JPA Health.
  • To support the National Recovery Campaign, the JPA Health team will:
    Conduct formative research using evidence-based practices to understand the needs for and barriers to accessing treatment and recovery supports.

Shatterproof Launches Bare Your Heart Campaign

Retrieved on: 
Friday, September 1, 2023
Technology, Other Health, Health, Philanthropy, General Health, Entertainment, Other Philanthropy, Mental Health, Apps, Applications, Audio, Video, Other Entertainment, Darkness, National Survey on Drug Use and Health, Suds, Life, Face, Culture, Light, Woman, Multimedia, Drug overdose, Bare, Internet, The 39 Clues, SUD, SAMSHA, Pharmaceutical industry, Addiction

Launching as part of Overdose Awareness Week, Shatterproof invites anyone with tattoos inspired by addiction, recovery or the loss of a loved one to share the story behind their body art through a campaign called Bare Your Heart.

Key Points: 
  • Launching as part of Overdose Awareness Week, Shatterproof invites anyone with tattoos inspired by addiction, recovery or the loss of a loved one to share the story behind their body art through a campaign called Bare Your Heart.
  • View the full release here: https://www.businesswire.com/news/home/20230901039813/en/
    Led by Shatterproof , a national nonprofit organization focused on guiding communities, removing systemic barriers to recovery, mobilizing the country to advocate for change, and ending addiction stigma in the U.S., Bare Your Heart is a campaign that will raise awareness about the impact of addiction with new digital audiences.
  • With the launch of Bare Your Heart, Shatterproof is partnering with influencer and TikToker, Lonni Pike (@grayhairandtattoos), who has more than 30 tattoos and uses her platform to challenge the stereotypes placed on women in their fifties with tattoos.
  • "Through the Bare Your Heart campaign, we aim to celebrate the incredible power of self-expression and storytelling embodied in tattoos.

NIAAA: Fall Semester--A Time for Parents To Discuss the Risks of College Drinking

Retrieved on: 
Monday, August 14, 2023
Substance Abuse, Education (Additional Support for Learning) (Scotland) Act 2004, Violence, National Institute on Alcohol Abuse and Alcoholism, Parent, Alcoholism, Substance Abuse and Mental Health Services Administration, Woman, National Survey on Drug Use and Health, BAC, Drinking, Binge drinking, AUD, Student, Death, Assault, NSDUH, Legal drinking age, Injury, SAMHSA, Nursing, Ridesharing

About 27.4% (i.e., 25.0% of males and 29.6% of females) of college students engaged in binge drinking during the same time frame.

Key Points: 
  • About 27.4% (i.e., 25.0% of males and 29.6% of females) of college students engaged in binge drinking during the same time frame.
  • These binge drinking and heavy alcohol use rates are both higher than for those not attending college.
  • The consequences of harmful and underage drinking by college students are more significant, more destructive, and more costly than many parents realize.
  • Research continues in order to better understand the relationships between alcohol and sexual assault among college students.

United States Tobacco Markets Report 2023: Demand for Premium Cigars Having a Positive Impact on the Near $100 Billion Industry

Retrieved on: 
Thursday, July 6, 2023
Smoker, Advertising, Employment, Travel, Smoking, Nicotine, Marketing, TB, Tobacco, Fatality, Tobacco industry, National Survey on Drug Use and Health, Centers for Disease Control and Prevention, Person, Attitude, Competition, Market, Death, State, Investment, Smokeless tobacco, Cigarette, Smoke, Stockholm Environment Institute US Center, Growth, Heated tobacco product, Ageing, Forecast, Legislation, Online shopping, Health

There are a number of elements that influence the tobacco market in the United States, including addiction, marketing and advertising, societal and economic concerns, and globalization.

Key Points: 
  • There are a number of elements that influence the tobacco market in the United States, including addiction, marketing and advertising, societal and economic concerns, and globalization.
  • The industry has also made significant investments in marketing and advertising to promote tobacco usage and smoking.
  • Due to growing consumer awareness of the negative effects of tobacco use, the demand for tobacco in the United States is predicted to be low.
  • Company Profiles: Detailed analysis of the major companies present in the United States tobacco market.

Recovery Centers of America Calls for End to Stigma During Mental Health Awareness Month

Retrieved on: 
Thursday, May 4, 2023
Learning, RCA, Substance Abuse, Depression, Sleep, Mirror Lake Recovery Center, Education, Life, Friends, Sleep deprivation, Anxiety, Mental health, DSM-IV codes, Grain boundary strengthening, Psychotherapy, National Survey on Drug Use and Health, Vegetable, Mental Health Awareness Month, Mental, Grief, MAT, Eating, Nursing, Cancer Treatment Centers of America, Physical fitness, Addiction, Mental health service, Memory, Irritability, Fatigue, Substance abuse, Health

King of Prussia, PA, May 04, 2023 (GLOBE NEWSWIRE) -- Recovery Centers of America (RCA), a healthcare network of substance use disorder treatment facilities on the East Coast and in the Midwest, today kicked off May as Mental Health Awareness Month with a call to end the stigma associated with mental health issues, and tips to help anyone – including those in recovery – improve their mental and emotional well-being.

Key Points: 
  • King of Prussia, PA, May 04, 2023 (GLOBE NEWSWIRE) -- Recovery Centers of America (RCA), a healthcare network of substance use disorder treatment facilities on the East Coast and in the Midwest, today kicked off May as Mental Health Awareness Month with a call to end the stigma associated with mental health issues, and tips to help anyone – including those in recovery – improve their mental and emotional well-being.
  • “Recovery Centers of America sees first-hand how prevalent mental health issues are – both as a root of substance abuse and a result of it.
  • About 53% (or 9 million adults) received either substance use treatment at a specialty facility or mental health services, though 84% received only mental health services, according to the survey.
  • If you or your loved one are struggling with addiction or mental health issues associated with addiction, the staff at Recovery Centers of America is here to help.

Clearmind Medicine Announces Clinical Supply Agreement for its Upcoming Clinical Trial

Retrieved on: 
Tuesday, May 2, 2023
National Survey on Drug Use and Health, GMP, CSE, Therapy, IMP, Clinical trial, GCP, FSE, AUD, Crave, GDP, Patient, CWY, Pharmaceutical industry, Health

IMP will be responsible for the global clinical supply chain of Clearmind’s proprietary drug candidate CMND-100 from manufacture to the various clinical sites.

Key Points: 
  • IMP will be responsible for the global clinical supply chain of Clearmind’s proprietary drug candidate CMND-100 from manufacture to the various clinical sites.
  • IMP is known for its comprehensive, tailor-made clinical supply services that address all study requirements.
  • Clinical drug supply is a critical factor for trial success so collaboration with best-in-class clinical drug supply vendor forestalls the possibility of it being a bottleneck to successful drug delivery.
  • Moreover, it can also deliver enormous benefits, including better investigator and patient experiences as well as cost savings in clinical drug supply.

Harris Teeter to Host Drug Take-Back Event on April 22 at several Charlotte-area stores

Retrieved on: 
Wednesday, April 19, 2023
Substance Abuse and Mental Health Services Administration, Substance Abuse, Partnership, Friends, SAFE, National Survey on Drug Use and Health, Psychological abuse, Plasma protein binding, DEA, Mental health service, Family, Pharmaceutical industry, Fair, Health

MATTHEWS, N.C., April 19, 2023 /PRNewswire-PRWeb/ -- Harris Teeter will host a drug take-back event at four of its Charlotte locations from 10 a.m. – 2 p.m. on Saturday, April 22, 2023, as part of the U.S. Drug Enforcement Administration's National Prescription Drug Take-Back Day. These events will provide a safe, convenient and anonymous way for local residents to dispose of unused or expired medications.

Key Points: 
  • MATTHEWS, N.C., April 19, 2023 /PRNewswire-PRWeb/ -- Harris Teeter will host a drug take-back event at four of its Charlotte locations from 10 a.m. – 2 p.m. on Saturday, April 22, 2023, as part of the U.S. Drug Enforcement Administration's National Prescription Drug Take-Back Day.
  • These events will provide a safe, convenient and anonymous way for local residents to dispose of unused or expired medications.
  • The goal is to help the police department keep medications off the street by proper disposal of prescription medications, and knowing the dangers associated with drug abuse.
  • You can find more information about Harris Teeter's commitment to drug disposal solutions on our website.

Clearmind Medicine Submits IND Application to FDA for its Proprietary CMND-100 Treating Alcohol Use Disorder

Retrieved on: 
Thursday, March 16, 2023
AUD, FSE, Norepinephrine, Mevalonate pathway, SERT, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, D-8 Organization for Economic Cooperation, Reward, MEAI, NET, Patient, Azerbaijan and Organization for Economic Co-operation, Parity, National Survey on Drug Use and Health, Death, Woman, Dopamine, CWY, FDA, Container deposit legislation in the United States, Clinical trial, Investigational New Drug, Food, Therapy, IND, Serotonin, DAT, CSE, Pharmaceutical industry, Health, Development

Tel Aviv, Israel / Vancouver, Canada, March 16, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced it has submitted an Investigational New Drug ("IND") application with the U.S. Food and Drug Administration ("FDA"), requesting approval to initiate its first-in-human Phase I/IIa clinical trial with CMND-100 in patients suffering from alcohol use disorder ("AUD"). Pending regulatory approval, the company plans to initiate the CMND-100 trial in Q2 2023.

Key Points: 
  • MEAI was found to interact with the serotonergic receptors 5-HT1a, 5-HT2a and 5-HT2b.
  • The serotonergic system is considered to play a key role in the regulation of alcohol intake, reward, preference, and dependence.
  • The IND submission to FDA, to initiate our clinical trial, is a milestone showing the huge commitment of the Clearmind team to finding a solution to this abusive disorder.
  • The economic loss results from missing labor days, resulting diseases, and other consequences of excessive alcohol use.